Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S298000, C514S657000, C514S356000, C514S461000, C514S448000, C562S466000, C549S484000, C549S071000
Reexamination Certificate
active
07872026
ABSTRACT:
Novel ligand compounds having the structural formula (I):in which:Ar is a radical selected from among the radical of formulae (a) to (c) below:are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively, into cosmetic compositions.
REFERENCES:
patent: 7148245 (2006-12-01), Bernardon et al.
patent: 2009/0023811 (2009-01-01), Biadatti et al.
patent: 0 952 974 (2001-11-01), None
Patani et. al., “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev. 1996, pp. 3147-3176.
Zcaplus 1999:166584 Abstract, “Biphenyl derivatives substituted by an aromatic or heteroaromatic radical for use in treating keratinization disorders”, Bernardon et. al., WO 9910308, Mar. 4, 1999.
International Search Report PCT/EP2004/014811 dated Mar. 10, 2005.
Biadatti Thibaud
Roye Olivier
Andres Janet L
Buchanan & Ingersoll & Rooney PC
Galderma Research & Development
Robinson Binta M
LandOfFree
Ligand activators of the RAR receptors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ligand activators of the RAR receptors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligand activators of the RAR receptors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2705656